Status:
UNKNOWN
Health Dialogue Intervention Versus Opportunistic Screening for Type 2 Diabetes and Cardiovascular Disease Prevention
Lead Sponsor:
Region Stockholm
Collaborating Sponsors:
Karolinska Institutet
Conditions:
Cardiovascular Diseases
Type 2 Diabetes
Eligibility:
All Genders
50-59 years
Phase:
NA
Brief Summary
Chronic diseases such as cardiovascular disease and diabetes type 2 are major causes of death worldwide. Preventive interventions can be delivered through primary care, as this is the first-line healt...
Detailed Description
DETECT (health Dialogue intErvention versus opporTunistic scrEening in primary Care for Type 2 diabetes and cardiovascular disease prevention) targets the challenges of primary prevention for individu...
Eligibility Criteria
Inclusion
- Primary care centres with a Care Need Index above 1.0
- Patients listed at the participating primary care centers.
Exclusion
- • None.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06067178
Start Date
December 1 2023
End Date
April 1 2025
Last Update
February 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for epidemiology and community medicine, Region Stockholm
Stockholm, Sweden, 10435